Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
24,762 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Navitas NVTS and ON Semiconductor are capturing attention as AI data-center demand climbs. Analysts see a potential r...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
AI is reshaping markets faster than many investors expect. This no-brainer artificial intelligence (AI) stock story b...
Chevron's CEO warns that jet fuel shortages may push aviation costs higher as carriers trim schedules and consumers f...
A hypothetical Berkshire Hathaway partnership with Aurora Innovation could lift investor sentiment and stock momentum...
Major acts are trimming or canceling large legs of US tours as fans face higher prices and travel costs. Industry wat...
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
The FHA's Mutual Mortgage Insurance Fund acts like a national mortgage insurance bag that helps millions buy homes. T...
As the economy ebbs and flows, some stocks stand out for their hard-to-replace value. This piece explores why costco ...
A leading AI scientist cautions that hyperintelligent machines with their own preservation goals could imperil humani...
Wells Fargo analysts warn the AI investment surge resembles a euphoric bubble, advising investors to ride gains while...